Can WhatsApp help heart patients sleep better?
NCT ID NCT06893575
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a 24-week sleep program delivered partly through WhatsApp for people with heart failure and poor sleep. The program included education, daily tips, and smartwatch sleep tracking. Researchers measured sleep quality, sleep habits, and quality of life in 28 participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- WhatsApp-based sleep health program
- What this could lead to
- If it works, this could offer a simple, low-cost way to help heart failure patients sleep better and feel better.
- What could go wrong
- This is a small, early study with only 28 participants, so results may not apply to everyone. The intervention relies on behavior change, which can be hard to maintain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
28 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 74 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Confirmed heart failure (HF) diagnosis for at least one year by a physician with echocardiographic verification. * Echocardiographically confirmed left ventricular ejection fraction (LVEF) \< 40%. * Individuals with poor sleep quality and experiencing sleep problems (PSQI score ≥ 5). * Not enrolled in any sleep improvement intervention program. * Possessing a device capable of using WhatsApp (smartphone, tablet, computer, etc.) and having the necessary technical proficiency. * Willingness to participate in the study Exclusion Criteria: * Presence of severe cognitive impairment (e.g., dementia, Alzheimer's disease) that may negatively affect the ability to use WhatsApp (Standardized Mini-Mental Test score \< 25). * Patients currently using sleep medications or sleep-regulating treatments. Individuals undergoing antidepressant or similar drug therapy. * Patients with significant communication difficulties due to hearing or visual impairments or language barriers.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Izzet Baysal Training and Research Hospital
Bolu, Bolu, 14230, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?